← Back to headlines
Eli Lilly in Talks to Acquire Kelonia Therapeutics for Over $2 Billion
Eli Lilly is reportedly in advanced discussions to acquire Kelonia Therapeutics for more than $2 billion, with a deal potentially finalized as early as Monday, according to The Wall Street Journal.
19 Apr, 22:38 — 19 Apr, 22:38
